Clinical outcome after management of unprotected left main in-stent restenosis after bare metal or drug-eluting stents.
Shao‐Liang Chen(Nanjing Medical University), Tak Kwan(North Shore University Hospital), Junjie Zhang(Jiangyin People's Hospital), Fei Ye(Nanjing Medical University), Aiping Zhang(Yangzhou University), Jinguo Chen, Jun Qian(Masteel (China)), Gary S. Mintz(Cardiovascular Research Foundation), Bo Xu(Hainan University), Jing Kan(Nanjing Medical University)
PubMed
April 5, 2010
Cited by 4
Related Papers
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
|Circulation|2020|9.4k
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
|Circulation|2019|9.1k
Consensus Standards for Acquisition, Measurement, and Reporting of Intravascular Optical Coherence Tomography Studies
|Journal of the American College of Cardiology|2012|1.8k
Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart Association
|Circulation|2021|796
A Paclitaxel-Eluting Stent for the Prevention of Coronary Restenosis
|New England Journal of Medicine|2003|456